Akari Therapeutics (AKTX) Net Cash Flow Growth (5y) (2019 - 2025)
Akari Therapeutics (AKTX) Net Cash Flow Growth (5y) (2019 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Regeneron Pharmaceuticals | 63.43 Bn | 54.67 Bn | 3.31 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 9.10% |
| Sep 30, 2025 | 20.47% |
| Jun 30, 2025 | -52.05% |
| Mar 31, 2025 | -14.96% |
| Dec 31, 2024 | 15.37% |
| Sep 30, 2024 | -20.63% |
| Jun 30, 2024 | 23.13% |
| Mar 31, 2024 | -53.57% |
| Dec 31, 2020 | 16.85% |
| Sep 30, 2020 | -14.97% |
| Jun 30, 2020 | 39.41% |
| Mar 31, 2020 | 25.19% |
| Dec 31, 2019 | -17.22% |
| Sep 30, 2019 | 23.19% |
| Jun 30, 2019 | -6.95% |
| Mar 31, 2019 | -42.54% |